

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | epoxygenase P450 pathway (GO:0019373) | 7.80524535 |
| 2 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 7.52389783 |
| 3 | L-phenylalanine catabolic process (GO:0006559) | 7.52389783 |
| 4 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 7.21190620 |
| 5 | L-phenylalanine metabolic process (GO:0006558) | 7.21190620 |
| 6 | aromatic amino acid family catabolic process (GO:0009074) | 6.80541909 |
| 7 | indole-containing compound catabolic process (GO:0042436) | 6.19040167 |
| 8 | indolalkylamine catabolic process (GO:0046218) | 6.19040167 |
| 9 | tryptophan catabolic process (GO:0006569) | 6.19040167 |
| 10 | kynurenine metabolic process (GO:0070189) | 5.96588834 |
| 11 | glyoxylate metabolic process (GO:0046487) | 5.95779767 |
| 12 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 5.92319263 |
| 13 | tryptophan metabolic process (GO:0006568) | 5.84333385 |
| 14 | bile acid biosynthetic process (GO:0006699) | 5.84178441 |
| 15 | regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081) | 5.73454033 |
| 16 | angiotensin maturation (GO:0002003) | 5.62883884 |
| 17 | omega-hydroxylase P450 pathway (GO:0097267) | 5.60965534 |
| 18 | cysteine metabolic process (GO:0006534) | 5.57522382 |
| 19 | urea metabolic process (GO:0019627) | 5.49033139 |
| 20 | urea cycle (GO:0000050) | 5.49033139 |
| 21 | alpha-linolenic acid metabolic process (GO:0036109) | 5.43426505 |
| 22 | sulfur amino acid catabolic process (GO:0000098) | 5.37201419 |
| 23 | negative regulation of fibrinolysis (GO:0051918) | 5.19630160 |
| 24 | high-density lipoprotein particle remodeling (GO:0034375) | 5.17036483 |
| 25 | serine family amino acid catabolic process (GO:0009071) | 5.13392583 |
| 26 | intestinal absorption (GO:0050892) | 5.10791004 |
| 27 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 5.08316466 |
| 28 | fat-soluble vitamin biosynthetic process (GO:0042362) | 5.06409923 |
| 29 | complement activation, alternative pathway (GO:0006957) | 5.06090125 |
| 30 | nitrogen cycle metabolic process (GO:0071941) | 5.06046711 |
| 31 | protein carboxylation (GO:0018214) | 5.06046630 |
| 32 | peptidyl-glutamic acid carboxylation (GO:0017187) | 5.06046630 |
| 33 | regulation of protein activation cascade (GO:2000257) | 5.03265650 |
| 34 | homocysteine metabolic process (GO:0050667) | 5.02746930 |
| 35 | regulation of fibrinolysis (GO:0051917) | 5.01864972 |
| 36 | lysine catabolic process (GO:0006554) | 4.98897234 |
| 37 | lysine metabolic process (GO:0006553) | 4.98897234 |
| 38 | aromatic amino acid family metabolic process (GO:0009072) | 4.96968107 |
| 39 | * bile acid metabolic process (GO:0008206) | 4.93405045 |
| 40 | hormone catabolic process (GO:0042447) | 4.86722953 |
| 41 | amino-acid betaine metabolic process (GO:0006577) | 4.70616750 |
| 42 | regulation of complement activation (GO:0030449) | 4.70181293 |
| 43 | tyrosine metabolic process (GO:0006570) | 4.69654076 |
| 44 | alpha-amino acid catabolic process (GO:1901606) | 4.64264532 |
| 45 | regulation of triglyceride catabolic process (GO:0010896) | 4.61530018 |
| 46 | bile acid and bile salt transport (GO:0015721) | 4.58742186 |
| 47 | regulation of cholesterol esterification (GO:0010872) | 4.54949020 |
| 48 | plasma lipoprotein particle remodeling (GO:0034369) | 4.53288649 |
| 49 | protein-lipid complex remodeling (GO:0034368) | 4.53288649 |
| 50 | macromolecular complex remodeling (GO:0034367) | 4.53288649 |
| 51 | reverse cholesterol transport (GO:0043691) | 4.51995714 |
| 52 | cellular ketone body metabolic process (GO:0046950) | 4.50834398 |
| 53 | triglyceride homeostasis (GO:0070328) | 4.46551559 |
| 54 | acylglycerol homeostasis (GO:0055090) | 4.46551559 |
| 55 | drug catabolic process (GO:0042737) | 4.43015677 |
| 56 | protein-lipid complex assembly (GO:0065005) | 4.42922927 |
| 57 | negative regulation of sterol transport (GO:0032372) | 4.42913792 |
| 58 | negative regulation of cholesterol transport (GO:0032375) | 4.42913792 |
| 59 | indolalkylamine metabolic process (GO:0006586) | 4.40151022 |
| 60 | coenzyme catabolic process (GO:0009109) | 4.33903889 |
| 61 | cellular glucuronidation (GO:0052695) | 4.33850485 |
| 62 | lipoprotein transport (GO:0042953) | 4.32828739 |
| 63 | protein activation cascade (GO:0072376) | 4.31918840 |
| 64 | cellular amino acid catabolic process (GO:0009063) | 4.31776761 |
| 65 | phospholipid efflux (GO:0033700) | 4.30595257 |
| 66 | glycine metabolic process (GO:0006544) | 4.29661174 |
| 67 | serine family amino acid metabolic process (GO:0009069) | 4.28380924 |
| 68 | glutamate metabolic process (GO:0006536) | 4.27419864 |
| 69 | ethanol metabolic process (GO:0006067) | 4.26634703 |
| 70 | amine catabolic process (GO:0009310) | 4.25769964 |
| 71 | cellular biogenic amine catabolic process (GO:0042402) | 4.25769964 |
| 72 | complement activation (GO:0006956) | 4.23125647 |
| 73 | cellular modified amino acid catabolic process (GO:0042219) | 4.20281623 |
| 74 | plasma lipoprotein particle organization (GO:0071827) | 4.17772515 |
| 75 | benzene-containing compound metabolic process (GO:0042537) | 4.17314814 |
| 76 | intestinal cholesterol absorption (GO:0030299) | 4.11939286 |
| 77 | drug transmembrane transport (GO:0006855) | 4.10430226 |
| 78 | imidazole-containing compound metabolic process (GO:0052803) | 4.08238347 |
| 79 | plasma lipoprotein particle clearance (GO:0034381) | 4.07654337 |
| 80 | urate metabolic process (GO:0046415) | 4.05910312 |
| 81 | acute-phase response (GO:0006953) | 4.04843074 |
| 82 | ethanol oxidation (GO:0006069) | 4.04359782 |
| 83 | serine family amino acid biosynthetic process (GO:0009070) | 4.03801016 |
| 84 | negative regulation of blood coagulation (GO:0030195) | 4.00066445 |
| 85 | negative regulation of hemostasis (GO:1900047) | 4.00066445 |
| 86 | lipoprotein metabolic process (GO:0042157) | 3.97258841 |
| 87 | NADH metabolic process (GO:0006734) | 3.96716699 |
| 88 | aldehyde catabolic process (GO:0046185) | 3.96436331 |
| 89 | exogenous drug catabolic process (GO:0042738) | 3.95939674 |
| 90 | cholesterol efflux (GO:0033344) | 3.95482573 |
| 91 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.94634119 |
| 92 | protein-lipid complex subunit organization (GO:0071825) | 3.94621013 |
| 93 | arginine metabolic process (GO:0006525) | 3.91271588 |
| 94 | ketone body metabolic process (GO:1902224) | 3.91258283 |
| 95 | uronic acid metabolic process (GO:0006063) | 3.90554185 |
| 96 | glucuronate metabolic process (GO:0019585) | 3.90554185 |
| 97 | short-chain fatty acid metabolic process (GO:0046459) | 3.87523831 |
| 98 | oxidative demethylation (GO:0070989) | 3.87473771 |
| 99 | alkaloid metabolic process (GO:0009820) | 3.86544207 |
| 100 | low-density lipoprotein particle remodeling (GO:0034374) | 3.86454045 |
| 101 | fructose metabolic process (GO:0006000) | 3.86421628 |
| 102 | diacylglycerol metabolic process (GO:0046339) | 3.81841990 |
| 103 | phenylpropanoid metabolic process (GO:0009698) | 3.80789320 |
| 104 | carboxylic acid catabolic process (GO:0046395) | 3.80080497 |
| 105 | organic acid catabolic process (GO:0016054) | 3.80080497 |
| 106 | plasma lipoprotein particle assembly (GO:0034377) | 3.79477041 |
| 107 | acetyl-CoA metabolic process (GO:0006084) | 3.78036838 |
| 108 | regulation of cholesterol homeostasis (GO:2000188) | 3.77278872 |
| 109 | fibrinolysis (GO:0042730) | 3.75516961 |
| 110 | negative regulation of coagulation (GO:0050819) | 3.74799874 |
| 111 | regulation of humoral immune response (GO:0002920) | 3.69617149 |
| 112 | cholesterol homeostasis (GO:0042632) | 3.69580581 |
| 113 | flavonoid metabolic process (GO:0009812) | 3.68521744 |
| 114 | cofactor catabolic process (GO:0051187) | 3.66083150 |
| 115 | phospholipid homeostasis (GO:0055091) | 3.66068557 |
| 116 | sterol homeostasis (GO:0055092) | 3.65086858 |
| 117 | aspartate family amino acid catabolic process (GO:0009068) | 3.64925323 |
| 118 | regulation of plasminogen activation (GO:0010755) | 3.63795640 |
| 119 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.61075949 |
| 120 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.61075949 |
| 121 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.59148984 |
| 122 | positive regulation of lipid catabolic process (GO:0050996) | 3.57620260 |
| 123 | drug metabolic process (GO:0017144) | 3.56977564 |
| 124 | * regulation of bile acid biosynthetic process (GO:0070857) | 3.56652968 |
| 125 | negative regulation of wound healing (GO:0061045) | 3.56112749 |
| 126 | negative regulation of protein activation cascade (GO:2000258) | 3.55986666 |
| 127 | polyketide metabolic process (GO:0030638) | 3.54838099 |
| 128 | doxorubicin metabolic process (GO:0044598) | 3.54838099 |
| 129 | daunorubicin metabolic process (GO:0044597) | 3.54838099 |
| 130 | blood coagulation, intrinsic pathway (GO:0007597) | 3.54807305 |
| 131 | complement activation, classical pathway (GO:0006958) | 3.53628865 |
| 132 | fatty acid oxidation (GO:0019395) | 3.53306522 |
| 133 | monocarboxylic acid catabolic process (GO:0072329) | 3.52069901 |
| 134 | fatty acid beta-oxidation (GO:0006635) | 3.51639654 |
| 135 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 3.47122546 |
| 136 | drug transport (GO:0015893) | 3.46196499 |
| 137 | negative regulation of lipase activity (GO:0060192) | 3.36902126 |
| 138 | heme transport (GO:0015886) | 3.35571770 |
| 139 | regulation of apoptotic cell clearance (GO:2000425) | 3.31941848 |
| 140 | regulation of guanylate cyclase activity (GO:0031282) | 3.30758897 |
| 141 | regulation of systemic arterial blood pressure by hormone (GO:0001990) | 3.29164470 |
| 142 | regulation of systemic arterial blood pressure mediated by a chemical signal (GO:0003044) | 3.29164470 |
| 143 | endocrine process (GO:0050886) | 3.29164470 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 8.28399549 |
| 2 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 7.14924809 |
| 3 | * EGR1_23403033_ChIP-Seq_LIVER_Mouse | 6.75444104 |
| 4 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 6.42225075 |
| 5 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 5.15749001 |
| 6 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 4.90122982 |
| 7 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.78352692 |
| 8 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.98002016 |
| 9 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 3.85426079 |
| 10 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 2.18403932 |
| 11 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.09501880 |
| 12 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 2.08626445 |
| 13 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.05726065 |
| 14 | * ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 11.6512859 |
| 15 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.93679929 |
| 16 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.64699444 |
| 17 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.64607886 |
| 18 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.58635526 |
| 19 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.50175523 |
| 20 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.47248651 |
| 21 | GATA1_22025678_ChIP-Seq_K562_Human | 1.47060592 |
| 22 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.43300044 |
| 23 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.40352743 |
| 24 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.35031651 |
| 25 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.32983204 |
| 26 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.25605605 |
| 27 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.18162788 |
| 28 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.17129748 |
| 29 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.15823509 |
| 30 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.14885079 |
| 31 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.14774398 |
| 32 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.09401802 |
| 33 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.04227746 |
| 34 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.04003564 |
| 35 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.00922498 |
| 36 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.94604704 |
| 37 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.93316728 |
| 38 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.93028483 |
| 39 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.88418592 |
| 40 | AR_21909140_ChIP-Seq_LNCAP_Human | 0.88143020 |
| 41 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 0.87890506 |
| 42 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.86750261 |
| 43 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.83205608 |
| 44 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.80979354 |
| 45 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.80626966 |
| 46 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.80454660 |
| 47 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.79652355 |
| 48 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.79204596 |
| 49 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.77216518 |
| 50 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.75931967 |
| 51 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.74758356 |
| 52 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.74538468 |
| 53 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.74410810 |
| 54 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.74111813 |
| 55 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.73091877 |
| 56 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.72052546 |
| 57 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.71350723 |
| 58 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.70985059 |
| 59 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.70852957 |
| 60 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.70606012 |
| 61 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.70497375 |
| 62 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.70158859 |
| 63 | SOX2_21211035_ChIP-Seq_LN229_Human | 0.69787445 |
| 64 | HNFA_21074721_ChIP-Seq_CACO-2_Human | 0.68764486 |
| 65 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.68160513 |
| 66 | JARID1B-DAIN_22020125_ChIP-Seq_ESCs_Mouse | 0.67429972 |
| 67 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 0.67398851 |
| 68 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 0.67198086 |
| 69 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.67083039 |
| 70 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.67083039 |
| 71 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.65475709 |
| 72 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.64733231 |
| 73 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.64627508 |
| 74 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 0.64601826 |
| 75 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.61912855 |
| 76 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.61790188 |
| 77 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.61599834 |
| 78 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.61119014 |
| 79 | NANOG_20526341_ChIP-Seq_ESCs_Human | 0.60474824 |
| 80 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.60391754 |
| 81 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.60129289 |
| 82 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.60055235 |
| 83 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.59535334 |
| 84 | EBNA1_20929547_Chip-Seq_RAJI-cells_Human | 0.59459776 |
| 85 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.59403626 |
| 86 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.58609335 |
| 87 | * GATA6_25053715_ChIP-Seq_YYC3_Human | 0.58331947 |
| 88 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.58276931 |
| 89 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.57905405 |
| 90 | CDX2_21074721_ChIP-Seq_CACO-2_Mouse | 0.57647020 |
| 91 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.57223028 |
| 92 | * DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.56428990 |
| 93 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.55979010 |
| 94 | TP63_23658742_ChIP-Seq_EP156T_Human | 0.55791199 |
| 95 | MYC_19915707_ChIP-ChIP_AK7_Human | 0.55768893 |
| 96 | * SA1_27219007_Chip-Seq_Bcells_Human | 0.55041875 |
| 97 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 0.54008469 |
| 98 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.53707472 |
| 99 | * AR_20517297_ChIP-Seq_VCAP_Human | 0.53581694 |
| 100 | * PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.52215648 |
| 101 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.51636042 |
| 102 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.51602593 |
| 103 | ESET_19884257_ChIP-Seq_ESCs_Mouse | 0.51404722 |
| 104 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.50599246 |
| 105 | STAT1_17558387_ChIP-Seq_HELA_Human | 0.50435109 |
| 106 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.48065628 |
| 107 | * CBP_21632823_ChIP-Seq_H3396_Human | 0.46785684 |
| 108 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.46308649 |
| 109 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.46147987 |
| 110 | P53_21459846_ChIP-Seq_SAOS-2_Human | 0.45985972 |
| 111 | GATA2_19941826_ChIP-Seq_K562_Human | 0.45262967 |
| 112 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.44809397 |
| 113 | * PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.44686965 |
| 114 | GATA1_19941826_ChIP-Seq_K562_Human | 0.44428359 |
| 115 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.43061671 |
| 116 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.42487700 |
| 117 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.42383286 |
| 118 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.42220326 |
| 119 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.41761728 |
| 120 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 0.40741280 |
| 121 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.40222024 |
| 122 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.39568250 |
| 123 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.38570128 |
| 124 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.38254377 |
| 125 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.38072719 |
| 126 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 0.37488178 |
| 127 | * CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.37465470 |
| 128 | CEBPB_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.37081766 |
| 129 | NCOR_22424771_ChIP-Seq_293T_Human | 0.37037824 |
| 130 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.35889752 |
| 131 | FOXH1_21741376_ChIP-Seq_EPCs_Human | 0.35823940 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 8.22779615 |
| 2 | MP0005360_urolithiasis | 7.84965384 |
| 3 | * MP0005085_abnormal_gallbladder_physiolo | 6.16114655 |
| 4 | MP0005365_abnormal_bile_salt | 6.09864062 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 5.19251045 |
| 6 | MP0003806_abnormal_nucleotide_metabolis | 4.04882119 |
| 7 | * MP0003252_abnormal_bile_duct | 3.61109213 |
| 8 | MP0010329_abnormal_lipoprotein_level | 3.43050020 |
| 9 | MP0009840_abnormal_foam_cell | 3.02325451 |
| 10 | MP0005332_abnormal_amino_acid | 2.99506899 |
| 11 | MP0003195_calcinosis | 2.98142208 |
| 12 | MP0005083_abnormal_biliary_tract | 2.89742991 |
| 13 | MP0001666_abnormal_nutrient_absorption | 2.78172501 |
| 14 | MP0004019_abnormal_vitamin_homeostasis | 2.51200325 |
| 15 | MP0003183_abnormal_peptide_metabolism | 2.44846535 |
| 16 | MP0003191_abnormal_cellular_cholesterol | 2.27286596 |
| 17 | MP0002138_abnormal_hepatobiliary_system | 2.26170257 |
| 18 | * MP0000609_abnormal_liver_physiology | 2.06969172 |
| 19 | * MP0002118_abnormal_lipid_homeostasis | 2.04967444 |
| 20 | MP0003868_abnormal_feces_composition | 2.02228060 |
| 21 | * MP0005319_abnormal_enzyme/_coenzyme | 1.77114499 |
| 22 | MP0001764_abnormal_homeostasis | 1.67857217 |
| 23 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.58645981 |
| 24 | MP0009643_abnormal_urine_homeostasis | 1.55110249 |
| 25 | MP0005451_abnormal_body_composition | 1.49538480 |
| 26 | MP0009697_abnormal_copulation | 1.36384705 |
| 27 | MP0010155_abnormal_intestine_physiology | 1.35417908 |
| 28 | MP0005409_darkened_coat_color | 1.28071324 |
| 29 | MP0003186_abnormal_redox_activity | 1.27965041 |
| 30 | MP0003879_abnormal_hair_cell | 1.21714868 |
| 31 | MP0004147_increased_porphyrin_level | 1.20737097 |
| 32 | MP0003011_delayed_dark_adaptation | 1.20025865 |
| 33 | MP0005636_abnormal_mineral_homeostasis | 1.18654315 |
| 34 | MP0009379_abnormal_foot_pigmentation | 1.16623187 |
| 35 | * MP0000598_abnormal_liver_morphology | 1.12555421 |
| 36 | MP0003705_abnormal_hypodermis_morpholog | 1.11305945 |
| 37 | MP0003656_abnormal_erythrocyte_physiolo | 1.09423176 |
| 38 | MP0005647_abnormal_sex_gland | 1.03165775 |
| 39 | MP0009764_decreased_sensitivity_to | 1.03134046 |
| 40 | MP0005084_abnormal_gallbladder_morpholo | 0.98220317 |
| 41 | MP0000604_amyloidosis | 0.93654014 |
| 42 | MP0005670_abnormal_white_adipose | 0.92418694 |
| 43 | MP0003866_abnormal_defecation | 0.90230509 |
| 44 | MP0001664_abnormal_digestion | 0.89697017 |
| 45 | * MP0009763_increased_sensitivity_to | 0.89015108 |
| 46 | * MP0009642_abnormal_blood_homeostasis | 0.88725859 |
| 47 | MP0002254_reproductive_system_inflammat | 0.88654617 |
| 48 | MP0005408_hypopigmentation | 0.87337897 |
| 49 | MP0002876_abnormal_thyroid_physiology | 0.87252093 |
| 50 | MP0006036_abnormal_mitochondrial_physio | 0.86473342 |
| 51 | * MP0008469_abnormal_protein_level | 0.84937211 |
| 52 | MP0001756_abnormal_urination | 0.84618136 |
| 53 | MP0000566_synostosis | 0.82081593 |
| 54 | MP0005220_abnormal_exocrine_pancreas | 0.81929128 |
| 55 | MP0002078_abnormal_glucose_homeostasis | 0.79684954 |
| 56 | MP0010368_abnormal_lymphatic_system | 0.79472782 |
| 57 | MP0002132_abnormal_respiratory_system | 0.78875593 |
| 58 | MP0005376_homeostasis/metabolism_phenot | 0.76005093 |
| 59 | MP0004043_abnormal_pH_regulation | 0.75650052 |
| 60 | MP0009765_abnormal_xenobiotic_induced | 0.75248473 |
| 61 | MP0002089_abnormal_postnatal_growth/wei | 0.70748317 |
| 62 | MP0000477_abnormal_intestine_morphology | 0.70283701 |
| 63 | MP0002971_abnormal_brown_adipose | 0.69907817 |
| 64 | MP0002136_abnormal_kidney_physiology | 0.69734953 |
| 65 | MP0001661_extended_life_span | 0.68611282 |
| 66 | MP0005334_abnormal_fat_pad | 0.68140502 |
| 67 | MP0000678_abnormal_parathyroid_gland | 0.66945766 |
| 68 | MP0004130_abnormal_muscle_cell | 0.63632028 |
| 69 | MP0005266_abnormal_metabolism | 0.61423337 |
| 70 | * MP0005535_abnormal_body_temperature | 0.60399235 |
| 71 | MP0009053_abnormal_anal_canal | 0.59671787 |
| 72 | MP0009785_altered_susceptibility_to | 0.58931281 |
| 73 | MP0002822_catalepsy | 0.58830630 |
| 74 | MP0002928_abnormal_bile_duct | 0.57553734 |
| 75 | MP0003690_abnormal_glial_cell | 0.56773484 |
| 76 | MP0006035_abnormal_mitochondrial_morpho | 0.56581894 |
| 77 | MP0005448_abnormal_energy_balance | 0.54829035 |
| 78 | MP0003329_amyloid_beta_deposits | 0.54604366 |
| 79 | MP0001765_abnormal_ion_homeostasis | 0.54280217 |
| 80 | MP0005023_abnormal_wound_healing | 0.52184554 |
| 81 | MP0003638_abnormal_response/metabolism_ | 0.51493467 |
| 82 | MP0000639_abnormal_adrenal_gland | 0.50728783 |
| 83 | MP0004264_abnormal_extraembryonic_tissu | 0.50177576 |
| 84 | MP0005666_abnormal_adipose_tissue | 0.49775152 |
| 85 | MP0005395_other_phenotype | 0.48913051 |
| 86 | MP0001663_abnormal_digestive_system | 0.48441201 |
| 87 | MP0004858_abnormal_nervous_system | 0.45745888 |
| 88 | MP0003953_abnormal_hormone_level | 0.45352681 |
| 89 | MP0008873_increased_physiological_sensi | 0.45227756 |
| 90 | MP0003724_increased_susceptibility_to | 0.44965468 |
| 91 | MP0005058_abnormal_lysosome_morphology | 0.44482132 |
| 92 | MP0005464_abnormal_platelet_physiology | 0.43421663 |
| 93 | MP0010234_abnormal_vibrissa_follicle | 0.42974364 |
| 94 | MP0000230_abnormal_systemic_arterial | 0.42342163 |
| 95 | MP0010352_gastrointestinal_tract_polyps | 0.41788196 |
| 96 | MP0000490_abnormal_crypts_of | 0.40905772 |
| 97 | MP0003718_maternal_effect | 0.40719236 |
| 98 | MP0004782_abnormal_surfactant_physiolog | 0.40684650 |
| 99 | MP0008874_decreased_physiological_sensi | 0.40439622 |
| 100 | MP0008872_abnormal_physiological_respon | 0.40120713 |
| 101 | MP0005166_decreased_susceptibility_to | 0.39901609 |
| 102 | MP0002796_impaired_skin_barrier | 0.39613969 |
| 103 | MP0001501_abnormal_sleep_pattern | 0.39407487 |
| 104 | MP0009384_cardiac_valve_regurgitation | 0.39279165 |
| 105 | MP0001915_intracranial_hemorrhage | 0.38503134 |
| 106 | MP0001873_stomach_inflammation | 0.38380587 |
| 107 | MP0000462_abnormal_digestive_system | 0.37935015 |
| 108 | MP0002168_other_aberrant_phenotype | 0.37008756 |
| 109 | MP0002837_dystrophic_cardiac_calcinosis | 0.36628370 |
| 110 | MP0000538_abnormal_urinary_bladder | 0.35866754 |
| 111 | MP0003075_altered_response_to | 0.35759888 |
| 112 | MP0009672_abnormal_birth_weight | 0.35698263 |
| 113 | MP0005381_digestive/alimentary_phenotyp | 0.34959154 |
| 114 | MP0004272_abnormal_basement_membrane | 0.33978275 |
| 115 | MP0005248_abnormal_Harderian_gland | 0.33609235 |
| 116 | MP0003436_decreased_susceptibility_to | 0.32962464 |
| 117 | MP0003300_gastrointestinal_ulcer | 0.32355948 |
| 118 | MP0009115_abnormal_fat_cell | 0.32014879 |
| 119 | MP0000579_abnormal_nail_morphology | 0.32013163 |
| 120 | MP0005164_abnormal_response_to | 0.31564268 |
| 121 | MP0001845_abnormal_inflammatory_respons | 0.30432076 |
| 122 | MP0002909_abnormal_adrenal_gland | 0.29831717 |
| 123 | MP0002135_abnormal_kidney_morphology | 0.29283017 |
| 124 | MP0002249_abnormal_larynx_morphology | 0.29165152 |
| 125 | MP0005167_abnormal_blood-brain_barrier | 0.28647574 |
| 126 | MP0002896_abnormal_bone_mineralization | 0.28529626 |
| 127 | MP0002970_abnormal_white_adipose | 0.28019318 |
| 128 | MP0001881_abnormal_mammary_gland | 0.26925179 |
| 129 | MP0000249_abnormal_blood_vessel | 0.26205527 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 7.17320311 |
| 2 | Intrahepatic cholestasis (HP:0001406) | 7.09387893 |
| 3 | Deep venous thrombosis (HP:0002625) | 6.80937786 |
| 4 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 6.46119565 |
| 5 | Xanthomatosis (HP:0000991) | 6.10264917 |
| 6 | Prolonged partial thromboplastin time (HP:0003645) | 6.05481340 |
| 7 | Hypobetalipoproteinemia (HP:0003563) | 6.01972203 |
| 8 | Hyperlipoproteinemia (HP:0010980) | 5.19623501 |
| 9 | Complement deficiency (HP:0004431) | 4.99957160 |
| 10 | Hyperammonemia (HP:0001987) | 4.60625351 |
| 11 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 4.59368779 |
| 12 | Hypolipoproteinemia (HP:0010981) | 4.50706338 |
| 13 | Joint hemorrhage (HP:0005261) | 4.45829492 |
| 14 | Hyperglycinemia (HP:0002154) | 4.40728533 |
| 15 | Ketosis (HP:0001946) | 4.38962485 |
| 16 | Epidermoid cyst (HP:0200040) | 4.31479067 |
| 17 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 4.28020610 |
| 18 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 4.27788962 |
| 19 | Hyperglycinuria (HP:0003108) | 4.24242328 |
| 20 | Abnormality of the common coagulation pathway (HP:0010990) | 4.18130536 |
| 21 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 4.13675298 |
| 22 | Fat malabsorption (HP:0002630) | 4.10522280 |
| 23 | Abnormality of glycine metabolism (HP:0010895) | 4.10518764 |
| 24 | Abnormality of serine family amino acid metabolism (HP:0010894) | 4.10518764 |
| 25 | Abnormality of methionine metabolism (HP:0010901) | 4.05586835 |
| 26 | Hypoglycemic coma (HP:0001325) | 3.94022534 |
| 27 | Hypoalphalipoproteinemia (HP:0003233) | 3.93903975 |
| 28 | Conjugated hyperbilirubinemia (HP:0002908) | 3.73941135 |
| 29 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.69093034 |
| 30 | Abnormality of complement system (HP:0005339) | 3.62503816 |
| 31 | Nephritis (HP:0000123) | 3.60966057 |
| 32 | Abnormality of the intrinsic pathway (HP:0010989) | 3.58603034 |
| 33 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.50389810 |
| 34 | Hypercholesterolemia (HP:0003124) | 3.43607643 |
| 35 | Ketoacidosis (HP:0001993) | 3.35120283 |
| 36 | Abnormality of nucleobase metabolism (HP:0010932) | 3.33666417 |
| 37 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.33420047 |
| 38 | Hyperbilirubinemia (HP:0002904) | 3.25018175 |
| 39 | Gout (HP:0001997) | 3.21473378 |
| 40 | Abnormality of purine metabolism (HP:0004352) | 3.15953109 |
| 41 | Delayed CNS myelination (HP:0002188) | 3.13650137 |
| 42 | Abnormality of serum amino acid levels (HP:0003112) | 3.05160282 |
| 43 | Steatorrhea (HP:0002570) | 3.03650253 |
| 44 | Osteomalacia (HP:0002749) | 2.98619641 |
| 45 | Hepatocellular carcinoma (HP:0001402) | 2.94248816 |
| 46 | Widely patent fontanelles and sutures (HP:0004492) | 2.92434207 |
| 47 | Metabolic acidosis (HP:0001942) | 2.88258964 |
| 48 | Spontaneous abortion (HP:0005268) | 2.81257712 |
| 49 | Potter facies (HP:0002009) | 2.80817004 |
| 50 | Facial shape deformation (HP:0011334) | 2.80817004 |
| 51 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.75432242 |
| 52 | Dicarboxylic aciduria (HP:0003215) | 2.75432242 |
| 53 | Vascular calcification (HP:0004934) | 2.74385604 |
| 54 | Myocardial infarction (HP:0001658) | 2.74057734 |
| 55 | Lethargy (HP:0001254) | 2.70970548 |
| 56 | Skin nodule (HP:0200036) | 2.66036382 |
| 57 | Ileus (HP:0002595) | 2.61311117 |
| 58 | Malnutrition (HP:0004395) | 2.60364169 |
| 59 | Systemic lupus erythematosus (HP:0002725) | 2.60277022 |
| 60 | Hypochromic microcytic anemia (HP:0004840) | 2.57822960 |
| 61 | Hyperphosphaturia (HP:0003109) | 2.57483722 |
| 62 | Pigmentary retinal degeneration (HP:0001146) | 2.57080138 |
| 63 | Generalized aminoaciduria (HP:0002909) | 2.53915083 |
| 64 | Hypoglycemic seizures (HP:0002173) | 2.51995922 |
| 65 | Abnormal urine phosphate concentration (HP:0012599) | 2.51265532 |
| 66 | Spastic diplegia (HP:0001264) | 2.46756443 |
| 67 | Irritability (HP:0000737) | 2.45381803 |
| 68 | Abnormality of the vitamin B12 metabolism (HP:0004341) | 2.43708037 |
| 69 | Hypophosphatemia (HP:0002148) | 2.42885943 |
| 70 | Cardiovascular calcification (HP:0011915) | 2.42767606 |
| 71 | Acanthocytosis (HP:0001927) | 2.42069737 |
| 72 | Cerebral edema (HP:0002181) | 2.40905716 |
| 73 | Alkalosis (HP:0001948) | 2.38589408 |
| 74 | Proximal tubulopathy (HP:0000114) | 2.36666914 |
| 75 | Neonatal onset (HP:0003623) | 2.36566947 |
| 76 | Late onset (HP:0003584) | 2.30267526 |
| 77 | Abnormal gallbladder morphology (HP:0012437) | 2.29491861 |
| 78 | Abnormality of vitamin B metabolism (HP:0004340) | 2.28481507 |
| 79 | Sensorimotor neuropathy (HP:0007141) | 2.28430731 |
| 80 | Enlarged kidneys (HP:0000105) | 2.28020119 |
| 81 | Mitral stenosis (HP:0001718) | 2.27095518 |
| 82 | Nephrolithiasis (HP:0000787) | 2.27023876 |
| 83 | Purpura (HP:0000979) | 2.25445190 |
| 84 | Increased purine levels (HP:0004368) | 2.25266365 |
| 85 | Hyperuricemia (HP:0002149) | 2.25266365 |
| 86 | Glomerulonephritis (HP:0000099) | 2.24151807 |
| 87 | Chronic diarrhea (HP:0002028) | 2.22929542 |
| 88 | Cholelithiasis (HP:0001081) | 2.22692499 |
| 89 | Vomiting (HP:0002013) | 2.22238546 |
| 90 | Cholecystitis (HP:0001082) | 2.22004406 |
| 91 | Abnormal gallbladder physiology (HP:0012438) | 2.22004406 |
| 92 | Nausea (HP:0002018) | 2.20024353 |
| 93 | Confusion (HP:0001289) | 2.19969013 |
| 94 | Pancreatitis (HP:0001733) | 2.19819105 |
| 95 | Abnormality of proline metabolism (HP:0010907) | 2.19555920 |
| 96 | Hydroxyprolinuria (HP:0003080) | 2.19555920 |
| 97 | Rickets (HP:0002748) | 2.17826444 |
| 98 | Esophageal varix (HP:0002040) | 2.16621459 |
| 99 | Abnormal tarsal ossification (HP:0008369) | 2.14806834 |
| 100 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.11684470 |
| 101 | Glycosuria (HP:0003076) | 2.10812903 |
| 102 | Abnormality of urine glucose concentration (HP:0011016) | 2.10812903 |
| 103 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.07343842 |
| 104 | Amyloidosis (HP:0011034) | 2.06790355 |
| 105 | Wide cranial sutures (HP:0010537) | 2.06645040 |
| 106 | Abnormality of alkaline phosphatase activity (HP:0004379) | 2.06272948 |
| 107 | Brushfield spots (HP:0001088) | 2.05638196 |
| 108 | Megaloblastic anemia (HP:0001889) | 2.05345485 |
| 109 | Abnormal enzyme/coenzyme activity (HP:0012379) | 2.02208019 |
| 110 | Elevated alkaline phosphatase (HP:0003155) | 1.99353055 |
| 111 | Menorrhagia (HP:0000132) | 1.98855229 |
| 112 | Opisthotonus (HP:0002179) | 1.98588121 |
| 113 | Cerebral palsy (HP:0100021) | 1.96759079 |
| 114 | Gingival bleeding (HP:0000225) | 1.96668126 |
| 115 | Thrombophlebitis (HP:0004418) | 1.96397473 |
| 116 | Flat acetabular roof (HP:0003180) | 1.95699646 |
| 117 | Abnormal cartilage morphology (HP:0002763) | 1.92505791 |
| 118 | Abnormality of the gallbladder (HP:0005264) | 1.92313729 |
| 119 | Hypophosphatemic rickets (HP:0004912) | 1.90660745 |
| 120 | Abnormality of vitamin metabolism (HP:0100508) | 1.89942223 |
| 121 | Focal segmental glomerulosclerosis (HP:0000097) | 1.89051713 |
| 122 | Hemorrhage of the eye (HP:0011885) | 1.88658317 |
| 123 | Renal cortical cysts (HP:0000803) | 1.86978022 |
| 124 | Abdominal distention (HP:0003270) | 1.83910994 |
| 125 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.83869831 |
| 126 | Poikilocytosis (HP:0004447) | 1.83622272 |
| 127 | Joint swelling (HP:0001386) | 1.81830535 |
| 128 | Hypotension (HP:0002615) | 1.79633343 |
| 129 | Abnormality of carpal bone ossification (HP:0006257) | 1.77417460 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 6.92977370 |
| 2 | ACVR1B | 5.50350936 |
| 3 | FGFR4 | 4.30909390 |
| 4 | ERN1 | 4.16051510 |
| 5 | SIK1 | 3.95682077 |
| 6 | MST1R | 3.30184143 |
| 7 | INSRR | 3.03046977 |
| 8 | TAOK3 | 2.99092844 |
| 9 | ERBB4 | 2.88437654 |
| 10 | PRKG2 | 2.60916902 |
| 11 | FRK | 2.31088674 |
| 12 | EPHA2 | 2.01137221 |
| 13 | MAP2K4 | 2.00178142 |
| 14 | PKN2 | 1.95876266 |
| 15 | MAPK11 | 1.91376181 |
| 16 | ICK | 1.85712307 |
| 17 | LMTK2 | 1.77014741 |
| 18 | LATS1 | 1.73210261 |
| 19 | STK39 | 1.71278234 |
| 20 | PIK3CG | 1.64833435 |
| 21 | FLT3 | 1.64020378 |
| 22 | MAP3K12 | 1.63421541 |
| 23 | PTK6 | 1.63103841 |
| 24 | TRIB3 | 1.59585981 |
| 25 | TYK2 | 1.45737773 |
| 26 | WNK4 | 1.38778346 |
| 27 | ABL2 | 1.34887642 |
| 28 | STK38L | 1.27622462 |
| 29 | NEK9 | 1.27329182 |
| 30 | MAP3K7 | 1.26338789 |
| 31 | PDK2 | 1.26319985 |
| 32 | MET | 1.25381198 |
| 33 | WNK3 | 1.25064416 |
| 34 | DDR2 | 1.24546028 |
| 35 | GRK6 | 1.18394007 |
| 36 | PRKAA2 | 1.18045705 |
| 37 | DAPK2 | 1.17418652 |
| 38 | JAK2 | 1.16921080 |
| 39 | FGFR2 | 1.13586489 |
| 40 | KDR | 1.13575699 |
| 41 | MAPK15 | 1.13407207 |
| 42 | PINK1 | 1.07432684 |
| 43 | ERBB2 | 1.03938814 |
| 44 | PDGFRA | 1.03395061 |
| 45 | NLK | 1.01909818 |
| 46 | MAP3K14 | 1.01187890 |
| 47 | MAP3K3 | 1.00467878 |
| 48 | EPHA4 | 0.98141036 |
| 49 | PRPF4B | 0.97723974 |
| 50 | MAP2K3 | 0.93976755 |
| 51 | MAP3K10 | 0.93344562 |
| 52 | TBK1 | 0.93286029 |
| 53 | EPHB1 | 0.89929662 |
| 54 | PIK3CA | 0.85597025 |
| 55 | OXSR1 | 0.85099539 |
| 56 | JAK1 | 0.84950494 |
| 57 | CASK | 0.82333335 |
| 58 | MAPK4 | 0.82254416 |
| 59 | IRAK3 | 0.81948421 |
| 60 | STK24 | 0.79374244 |
| 61 | RIPK1 | 0.79307375 |
| 62 | DYRK1B | 0.78406986 |
| 63 | MAP3K2 | 0.77399977 |
| 64 | FER | 0.77051432 |
| 65 | GSK3A | 0.75774994 |
| 66 | MATK | 0.75107639 |
| 67 | TESK2 | 0.74026656 |
| 68 | SGK3 | 0.74022170 |
| 69 | PRKAA1 | 0.73907900 |
| 70 | MAP2K6 | 0.72287029 |
| 71 | TIE1 | 0.72142414 |
| 72 | PRKACG | 0.72051201 |
| 73 | PTK2 | 0.71655229 |
| 74 | CAMK2G | 0.67535873 |
| 75 | MAP3K11 | 0.67458891 |
| 76 | CSK | 0.67103707 |
| 77 | EPHA3 | 0.66127246 |
| 78 | CDK6 | 0.65605755 |
| 79 | CDC42BPA | 0.64100595 |
| 80 | MAPK12 | 0.62156881 |
| 81 | MAP2K2 | 0.59968344 |
| 82 | PDK4 | 0.59663522 |
| 83 | PDK3 | 0.59663522 |
| 84 | SGK494 | 0.58376041 |
| 85 | SGK223 | 0.58376041 |
| 86 | TNIK | 0.58178920 |
| 87 | TGFBR2 | 0.57999403 |
| 88 | MAP2K1 | 0.57109697 |
| 89 | SGK2 | 0.55971504 |
| 90 | SRC | 0.55262064 |
| 91 | PDPK1 | 0.52627852 |
| 92 | MELK | 0.51769178 |
| 93 | * PRKCZ | 0.49094417 |
| 94 | FGFR1 | 0.47741396 |
| 95 | CAMK1D | 0.47000664 |
| 96 | NEK6 | 0.46244526 |
| 97 | FGFR3 | 0.45969281 |
| 98 | IKBKE | 0.45017174 |
| 99 | PRKCQ | 0.44966924 |
| 100 | CDK12 | 0.44898789 |
| 101 | GRK1 | 0.43420102 |
| 102 | EEF2K | 0.43213180 |
| 103 | EPHB2 | 0.41946705 |
| 104 | IGF1R | 0.41020976 |
| 105 | PRKG1 | 0.40885591 |
| 106 | CSNK1G1 | 0.40222286 |
| 107 | RET | 0.39206587 |
| 108 | MAPK7 | 0.38646530 |
| 109 | MAP3K13 | 0.37454602 |
| 110 | KSR2 | 0.37122823 |
| 111 | MAP4K1 | 0.36495604 |
| 112 | PRKACA | 0.35556833 |
| 113 | BMPR2 | 0.33947126 |
| 114 | MAP3K1 | 0.33793820 |
| 115 | AKT3 | 0.33644502 |
| 116 | ZAP70 | 0.33240137 |
| 117 | IRAK2 | 0.32234101 |
| 118 | PIM1 | 0.31898568 |
| 119 | MAP3K5 | 0.31767314 |
| 120 | PDK1 | 0.31027532 |
| 121 | MAPKAPK3 | 0.30805137 |
| 122 | MTOR | 0.30431902 |
| 123 | CSF1R | 0.30385924 |
| 124 | MST4 | 0.30373796 |
| 125 | MAP3K6 | 0.30349296 |
| 126 | IRAK1 | 0.30092145 |
| 127 | PAK3 | 0.29961500 |
| 128 | BRSK2 | 0.28696223 |
| 129 | SGK1 | 0.28074459 |
| 130 | TAOK2 | 0.27043122 |
| 131 | PRKCG | 0.26420203 |
| 132 | EGFR | 0.26401991 |
| 133 | CDK4 | 0.25539617 |
| 134 | PKN1 | 0.25373629 |
| 135 | CDK9 | 0.24753164 |
| 136 | NEK1 | 0.24703336 |
| 137 | FYN | 0.24515443 |
| 138 | * PRKCA | 0.24209281 |
| 139 | MYLK | 0.22888019 |
| 140 | YES1 | 0.22728921 |
| 141 | PRKCB | 0.21916877 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.33695349 |
| 2 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.44421438 |
| 3 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.40520315 |
| 4 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.26909096 |
| 5 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.95075233 |
| 6 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.73173713 |
| 7 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.65564871 |
| 8 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.59056949 |
| 9 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.54401810 |
| 10 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.52327848 |
| 11 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.50485941 |
| 12 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.46157625 |
| 13 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.37492041 |
| 14 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.30473261 |
| 15 | Peroxisome_Homo sapiens_hsa04146 | 2.14046247 |
| 16 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.08689257 |
| 17 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.00277351 |
| 18 | Histidine metabolism_Homo sapiens_hsa00340 | 1.90461771 |
| 19 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.89400167 |
| 20 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.88311211 |
| 21 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.86755706 |
| 22 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.84253313 |
| 23 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.79509728 |
| 24 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.73871611 |
| 25 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.72798968 |
| 26 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.71801183 |
| 27 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.71505994 |
| 28 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.67093190 |
| 29 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.64820103 |
| 30 | Retinol metabolism_Homo sapiens_hsa00830 | 1.64231532 |
| 31 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.59604909 |
| 32 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.58054820 |
| 33 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.56974545 |
| 34 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.56208161 |
| 35 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.52723737 |
| 36 | * Bile secretion_Homo sapiens_hsa04976 | 1.51510284 |
| 37 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.46354559 |
| 38 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.42311429 |
| 39 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.36449715 |
| 40 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.36431338 |
| 41 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.26907706 |
| 42 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.26423969 |
| 43 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.24789996 |
| 44 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.23871638 |
| 45 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.20959317 |
| 46 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.20019157 |
| 47 | ABC transporters_Homo sapiens_hsa02010 | 1.18134491 |
| 48 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.17296640 |
| 49 | Carbon metabolism_Homo sapiens_hsa01200 | 1.17110131 |
| 50 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.12537538 |
| 51 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.11040208 |
| 52 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.07887817 |
| 53 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.02097515 |
| 54 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.01880743 |
| 55 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.91953395 |
| 56 | Sulfur relay system_Homo sapiens_hsa04122 | 0.89265665 |
| 57 | Lysine degradation_Homo sapiens_hsa00310 | 0.85231797 |
| 58 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.84703075 |
| 59 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.82109124 |
| 60 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.76202824 |
| 61 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.74816051 |
| 62 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.73813933 |
| 63 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.66754194 |
| 64 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.66154029 |
| 65 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.60248267 |
| 66 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.49991010 |
| 67 | Metabolic pathways_Homo sapiens_hsa01100 | 0.47962362 |
| 68 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.41968509 |
| 69 | Other glycan degradation_Homo sapiens_hsa00511 | 0.39002830 |
| 70 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.37809087 |
| 71 | Pertussis_Homo sapiens_hsa05133 | 0.36527648 |
| 72 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.35538759 |
| 73 | Galactose metabolism_Homo sapiens_hsa00052 | 0.33544189 |
| 74 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.32340699 |
| 75 | Prion diseases_Homo sapiens_hsa05020 | 0.30595639 |
| 76 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.27039659 |
| 77 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.24972683 |
| 78 | Insulin resistance_Homo sapiens_hsa04931 | 0.22958674 |
| 79 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.20325966 |
| 80 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.17808434 |
| 81 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.16014449 |
| 82 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.09116822 |
| 83 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.06949523 |
| 84 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.01842572 |
| 85 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.00218259 |
| 86 | Ether lipid metabolism_Homo sapiens_hsa00565 | -0.2373097 |
| 87 | Bladder cancer_Homo sapiens_hsa05219 | -0.2096645 |
| 88 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | -0.2022596 |
| 89 | African trypanosomiasis_Homo sapiens_hsa05143 | -0.1960327 |
| 90 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | -0.1832360 |
| 91 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | -0.1810149 |
| 92 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | -0.1672897 |
| 93 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | -0.1649181 |
| 94 | Hepatitis C_Homo sapiens_hsa05160 | -0.1445218 |
| 95 | Regulation of autophagy_Homo sapiens_hsa04140 | -0.1291894 |
| 96 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | -0.1252118 |
| 97 | Protein digestion and absorption_Homo sapiens_hsa04974 | -0.1221728 |
| 98 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | -0.1158474 |
| 99 | Insulin signaling pathway_Homo sapiens_hsa04910 | -0.1141693 |
| 100 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | -0.1021119 |
| 101 | Serotonergic synapse_Homo sapiens_hsa04726 | -0.0939965 |
| 102 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | -0.0897631 |
| 103 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | -0.0896396 |
| 104 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | -0.0867183 |
| 105 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | -0.0857231 |
| 106 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | -0.0811603 |
| 107 | Amoebiasis_Homo sapiens_hsa05146 | -0.0609758 |
| 108 | Mineral absorption_Homo sapiens_hsa04978 | -0.0387445 |
| 109 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | -0.0280475 |
| 110 | Asthma_Homo sapiens_hsa05310 | -0.0179004 |
| 111 | Renin-angiotensin system_Homo sapiens_hsa04614 | -0.0157998 |

